Search

everythinglearnresearchcommunity

for

Search:↓

There is no causal relationship between androgenetic alopecia and serum uric acid.

A patient with steroid sulfatase deficiency had a unique hair pattern and a brain malformation not previously linked to the condition.

N‐AOHPA is a promising alternative to traditional surfactants for better hair conditioning.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Stem cells from hair follicles can safely treat hair loss.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Minoxidil helps hair growth and reduces shedding in women.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.